Mostrando estudio seleccionado:
TECAM PILOT |
Feasibility and safety study of percutaneous implantation of bone marrow stem cells for regenerating infarcted myocardial tissue and preventing post-infarct heart failure |
Coordinator: ICICOR Area of Research: Cell Therapy Services provided: 200 complete angiographic studies, 128 cardiac MRI studies, quantitative IVUS analysis of 90 patients, and stress echocardiography with dobutamine for 140 patients
Publications:
Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 2004; 95: 742-748.
Intracoronary stem cell transplantation in acute myocardial infarction. Rev Esp Cardiol. 2004; 57: 201-8.
Impacto de la obstrucción microvascular persistente en el remodelado ventricular postinfarto tras el implante intracoronario de células mononucleadas de médula ósea: un estudio de cardiorresonancia con contraste. Rev Esp Cardiol 2008; 61: 602-10.
Comparison of neointimal hyperplasia with drug-eluting stents versus bare metal stents in patients undergoing intracoronary bone-marrow mononuclear cell transplantation following acute myocardial infarction. Am J Cardiol 2009; 103: 1651-6
Absence of accelerated atherosclerotic disease progression after intracoronary infusion of bone marrow derived mononuclear cells in patients with acute myocardial infarction--angiographic and intravascular ultrasound-results from the TErapia Celular Aplicada al Miocardio Pilot study. Am Heart J. 2010;159:1154.-8. |